Stock·NASDAQ·Industrials
AeroVironment, Inc. (AVAV)
- Market cap
- $6.19B
- Dividend yield
- 0.00%
- Street target
- $220.00median of 22 analysts
- 52-week range
- $116.43 $408.25
The short version
Where AVAV stands today, in four lines, and what CleaRank Financial AI makes of it.
AVAV at a glance
AeroVironment, Inc. (AVAV): Sell, 32/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($153.20 and $195.53).
- Earnings AVAV beat estimates in 3 of its last 7 quarters, and the stock rose the next day every time.
- Insiders Insiders sold $7.7M and made no open-market purchases over the last 18 months.
Figures as of October 17, 2026.
CleaRank Financial AI
CleaRank rates AeroVironment, Inc. (AVAV) Sell, with a model score of 32/100.
The analysts' outlook lifts the score most: 17 of 22 analysts rate it a buy and the median target is 80.6% above the price. The trend holds it back most: the price is 37.71% below its 200-day average and 20.50% below its 50-day average, and the 50-day average is 21.65% below the 200-day. The 50-day average stands at $153.20 and the 200-day at $195.53. Over the past year the price fell 67.44%.
Only on CleaRank
Figures we compute ourselves from AVAV's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $121.79 is 20.5% below the 50-day simple moving average of $153.20.Price above its 200-day average ›
The price is 37.7% below the 200-day simple moving average of $195.53.50-day average above the 200-day ›
The 50-day average ($153.20) is 21.6% below the 200-day average ($195.53), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 2% of its 52-week range, between $116.43 and $408.25.
AVAV share price
Pick a period: each tab shows how far AVAV has moved over it, to the last close.
Today's trading
Where AVAV sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
1/3P/S below the sector median ›
The price-to-sales ratio of 3.13 is 21.8% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $-202.8M on revenue of $2.0B, a net margin of -10.1%.Beat estimates in most recent reports ›
AVAV beat the EPS estimate in 3 of its last 7 reports.
Key statistics
The headline figures for AVAV.
As of October 17, 2026, AVAV trades at $121.79, with a market value of $6.19B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of AVAV's valuation, growth and risks.
AVAV's P/E cannot be read, because the company lost money over the last 12 months, so the result is not meaningful. Its price-to-sales ratio of 3.13 is 21.8% below the sector median of 4.0. To put the size in context, AVAV carries a market capitalisation of $6.2B.
The company is losing money, with a net margin of -10.13% and an operating margin of -2.27%. Growth trails the sector: revenue grew 5.70% in the latest year, against a sector median of 11.7%. It reports a return on equity of -4.60%, below the sector median of 17.8%. Rounding out the fundamentals, AVAV reports debt-to-equity of 0.19.
AVAV's most recent quarterly report, released on September 9, 2026, came in above forecasts: EPS of $0.59 a share compared with a $0.25 estimate, a beat of 136.00%. In the first session after the report, the share price climbed 4.45%.
Over its last 7 reports, AVAV topped the estimate 3 times, and every one of those beats was followed by a gain the next day. The largest of the earlier reactions came after the June 29, 2026 report, which beat the estimate by 25.17% while the stock rose 18.76%. The consensus EPS estimate stands at $3.26 for this fiscal year and $4.45 for next, a decline of 1.4% for the current year.
Daily swings are the first thing to plan around, since AVAV has moved 2.81% on an average session. The trend stays a headwind for holders until the price gets back above its moving averages. The price is 70.17% under its 52-week high of $408.25. Over the last 18 months insiders sold $7.7M and made no open-market purchases. Those sales are often planned in advance, so they tell less than purchases would.
AVAV against the Industrials sector
How AVAV compares with the median Industrials stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, AVAV trades at 3.13x, -22% versus the sector average of 4.00x.
Return vs XLI: Since May 6, 2025, AVAV has lost 23.2% against a gain of 25.7% for XLI.
Performance against XLI
AVAV and the Industrials sector fund over the same days.
Revenue and earnings
How much AVAV sells, and how much of it becomes profit.
Revenue growth: Revenue grew 140.9% in FY2026 to $2.0B, from $821M a year earlier.
Profit margin: The net margin was -13.4% in FY2026, down from 5.3% the year before.
Loss-making: AVAV lost $265M in FY2026.
Earnings reality check
Did AVAV beat what analysts expected, and how did the stock react?
Earnings record: AVAV beat the analyst estimate in 3 of the last 7 quarters.
Market reaction: The stock rose in the first session after every beat.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Sep 9, 2026after close | $0.25 | $0.59 | +136.00% | +4.45% | +11.12% |
| Jun 29, 2026after close | $1.47 | $1.84 | +25.17% | +18.76% | +16.93% |
| Mar 10, 2026after close | $0.69 | $0.64 | -7.25% | -6.25% | +0.42% |
| Dec 9, 2025after close | $0.79 | $0.44 | -44.30% | -12.85% | -16.62% |
| Jun 24, 2025after close | $1.39 | $1.61 | +15.83% | +21.55% | +30.59% |
| Mar 4, 2025after close | $0.72 | $0.30 | -58.33% | -4.38% | -12.61% |
| Dec 4, 2024after close | $0.68 | $0.47 | -30.88% | -15.88% | -21.61% |
As of October 17, 2026, AVAV has beaten the analyst EPS estimate in 3 of its last 7 reported quarters and rose in the first trading session after every one of those beats; its latest report, on September 9, 2026, came in 136.00% above the estimate and the stock moved +4.45% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
0/3RSI not overbought or oversold ›
The 14-day RSI is 28.6, in oversold territory.RSI above 50 ›
An RSI of 28.6 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of AVAV
The score, the reasoning behind it, and what could move the price next.
AeroVironment, Inc. (AVAV) is trending down. At $121.79, the stock sits 20.50% below its 50-day average of $153.20 and 37.71% below its 200-day average of $195.53. Near the bottom of its 52-week range, the price is 4.60% above the low of $116.43 and 70.17% below the high of $408.25. The 50-day average is 21.65% below the 200-day, a pattern that backs up the weakness rather than cutting against it.
The 14-day RSI of 28.6 is in oversold territory, and the MACD line is negative. The record is negative across every period shown: the price fell 14.35% over the past three months, fell 36.38% over the past six months and fell 67.44% over the past year.
Earnings beat ›
The September 9, 2026 report beat the EPS estimate by 136.00%, and the share price rose 4.45% in the first session after it.
Source: Earnings report, September 9, 2026New analyst coverage ›
Rothschild & Co started coverage at Neutral on October 6, 2026.
Source: Analyst action, Rothschild & Co, October 6, 2026
New analyst coverage ›
Barclays started coverage at Equal-Weight on October 9, 2026.
Source: Analyst action, Barclays, October 9, 2026
- Two levels matter most right now: the 20-day EMA at $137.43, which sits above the price, and the 52-week low at $116.43, which sits below it.
- The 14-day RSI reads 28.6, in the oversold zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- The share price rose 4.45% in the first session after the September 9, 2026 report. Across the record, AVAV has beaten estimates in 3 of the last 7 reports.
AVAV is held under both its 50-day average of $153.20 and its 200-day average of $195.53, and that pattern is why the trend reads down. A recovery would start with a move back above the 50-day. Right now the first level overhead is the 20-day EMA at $137.43.
The next level below the price is the 52-week low at $116.43.
Technical indicators
Momentum and trend for AVAV, from its daily closes.
As of October 17, 2026, with AVAV at $121.79, its 14-day RSI is 28.6 (oversold territory), its 50-day simple moving average is $153.20 and its 200-day is $195.53.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What AVAV moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, AVAV's 1-year correlation of daily returns is +0.33 with S&P 500 (SPY), +0.33 with Nasdaq 100 (QQQ), +0.22 with Bitcoin (BTC) and +0.13 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
17 of 22 analysts rate it a buy or strong buy, 5 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $220.00 is 80.6% above the price.More buy ratings than three months ago ›
17 of 22 rate it a buy now, against 17 of 20 three months ago.
AVAV Wall Street View
12-month price targets
The price, $121.79, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 9, 2026 | Barclays | Initiates | Equal-Weight |
| Oct 6, 2026 | Rothschild & Co | Initiates | Neutral |
| Sep 16, 2026 | Jefferies | Maintains | Buy |
| Sep 11, 2026 | B of A Securities | Maintains | Buy |
| Sep 10, 2026 | Citizens | Reiterates | Market Outperform |
| Sep 10, 2026 | JP Morgan | Maintains | Overweight |
As of October 17, 2026, 22 Wall Street analysts cover AVAV: 17 rate it a buy or strong buy, 5 a hold and 0 a sell or strong sell. Their 12-month price targets range from $148.57 to $315.00, with a median of $220.00, 80.6% above the price of $121.79.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
AVAV trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from AVAV's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much AVAV tends to move, against the market and on its own.
The long record
AVAV's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 2.81% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 70.6%, from October 2025 to October 2026; the price is still 70.3% below that peak.Most 1-year holds ended higher ›
70% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $54,639, against $42,055 in the S&P 500 (SPY).
AVAV Drawdowns & Recovery
As of October 17, 2026, AVAV's worst peak-to-trough fall over the last 10 years with dividends reinvested was -70.6% (October 2025 to October 2026); it is still 70.3% below that peak, and 70% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into AVAV in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: AVAV beat the S&P 500 over this period: $54,639 against $42,055.
A $10,000 investment in AVAV in October 2016 would be worth about $54,639 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to AVAV, and which have not.
Strongest month, January: an average of +7.49%, up in 6 of 10 years.
Weakest month, December: an average of -5.08%, up in 3 of 10 years.
This month, October: has averaged +6.05%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, AVAV's strongest calendar month has been January (average +7.49%, up in 6 of 10 years) and its weakest December (average -5.08%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in AVAV, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in AVAV today could grow to about $25,899 by 2036 in the base case, with a 90th-percentile outcome near $196,485 and a 10th-percentile outcome around $3,414. Projections are statistical simulations, not guarantees.
AVAV Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $178 for AVAV by 2030 in the base case, from $122 today (1.5x over 4 years). The 10th-percentile path ends near $49.47. These are outcomes of a Monte Carlo simulation run on AVAV's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $70.57 | $134 | $254 | |
| 2028 | $59.52 | $147 | $365 | |
| 2029 | $53.40 | $162 | $492 | |
| 2030 | $49.47 | $178 | $642 | |
| 2031 | $46.77 | $196 | $821 |
Method: a lognormal simulation of AVAV's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. AVAV is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
AVAV insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: No insider bought AVAV shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 17, 2026, AVAV insiders reported 24 open-market sales worth $7.7M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Stephen F Page
Director
|
Sell | 250 | $38.1K |
| Sep 15, 2026 | Brian Charles Shackley
Officer
|
Sell | 100 | $15.2K |
| Sep 14, 2026 | Michael D. Ruppert
Director
|
Grant | 957 | - |
| Aug 17, 2026 | Stephen F Page
Director
|
Sell | 250 | $48.0K |
| Aug 14, 2026 | Brian Charles Shackley
Officer
|
Sell | 205 | $41.4K |
| Jul 15, 2026 | Brian Charles Shackley
Officer
|
Sell | 300 | $42.9K |
| Jul 15, 2026 | Stephen F Page
Director
|
Sell | 248 | $35.5K |
| Jul 2, 2026 | Melissa Ann Brown
Officer
|
Grant | 1.7K | - |
| Jul 2, 2026 | Charles Thomas Burbage
Director
|
Grant | 1.2K | - |
| Jul 2, 2026 | Phillip S Davidson
Director
|
Grant | 1.2K | - |
| Jul 2, 2026 | Cindy Kay Lewis
Director
|
Grant | 1.3K | - |
| Jul 2, 2026 | Mary Beth Long
Director
|
Grant | 1.2K | - |
| Jul 2, 2026 | William Lynn III
Director
|
Grant | 892 | - |
| Jul 2, 2026 | Clum Mary Elizabeth Mcdaniel
Officer
|
Grant | 1.2K | - |
| Jul 2, 2026 | Edward R Muller
Director
|
Grant | 1.4K | - |
| Jul 2, 2026 | Wahid Nawabi
Chief Executive Officer
|
Grant | 15.8K | $13.6K |
| Jul 2, 2026 | Stephen F Page
Director
|
Grant | 1.2K | - |
| Jul 2, 2026 | Brian Charles Shackley
Officer
|
Grant | 698 | - |
| Jul 2, 2026 | Robert Fendlay Smith
Chief Operating Officer
|
Grant | 2.0K | - |
| Jul 2, 2026 | Trace E Stevenson
Officer
|
Grant | 2.4K | - |
| Jul 2, 2026 | Joseph L. Votel
Director
|
Grant | 1.3K | - |
| Jul 2, 2026 | Sean Thomas Woodward
Chief Financial Officer
|
Grant | 2.2K | $13.6K |
| Jun 29, 2026 | Melissa Ann Brown
Officer
|
Grant | 9.2K | - |
| Jun 29, 2026 | Wahid Nawabi
Chief Executive Officer
|
Grant | 57.7K | - |
| Jun 29, 2026 | Brian Charles Shackley
Officer
|
Grant | 2.4K | - |
| Jun 29, 2026 | Trace E Stevenson
Officer
|
Grant | 4.8K | - |
| Jun 29, 2026 | Sean Thomas Woodward
Chief Financial Officer
|
Grant | 2.4K | - |
| Jun 15, 2026 | Stephen F Page
Director
|
Sell | 250 | $43.6K |
| May 15, 2026 | Stephen F Page
Director
|
Sell | 250 | $40.6K |
| Apr 15, 2026 | Stephen F Page
Director
|
Sell | 250 | $49.3K |
| Apr 13, 2026 | Robert Fendlay Smith
Chief Operating Officer
|
Grant | 1.8K | $349.9K |
| Mar 16, 2026 | Stephen F Page
Director
|
Sell | 250 | $53.1K |
| Mar 16, 2026 | Brian Charles Shackley
Officer
|
Sell | 200 | $42.5K |
| Mar 16, 2026 | Brian Charles Shackley
Officer
|
Grant | 707 | - |
| Mar 10, 2026 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Sell | 396 | $88.9K |
| Mar 2, 2026 | Stephen F Page
Director
|
Sell | 250 | $52.1K |
| Feb 19, 2026 | Stephen F Page
Director
|
Sell | 250 | $68.8K |
| Feb 17, 2026 | Stephen F Page
Director
|
Sell | 500 | $127.5K |
| Feb 10, 2026 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Sell | 879 | $235.2K |
| Jan 15, 2026 | Stephen F Page
Director
|
Sell | 1.0K | $377.6K |
| Jan 12, 2026 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Sell | 999 | $367.2K |
| Dec 30, 2025 | Brian Charles Shackley
Officer
|
Sell | 200 | $50.2K |
| Dec 10, 2025 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Sell | 511 | $127.4K |
| Nov 10, 2025 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Sell | 513 | $170.0K |
| Oct 10, 2025 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Sell | 998 | $398.9K |
| Oct 6, 2025 | Trace E Stevenson
Officer
|
Sell | 1.7K | $654.2K |
| Jul 16, 2025 | Wahid Nawabi
Chief Executive Officer
|
Sell | 17.3K | $4.6M |
| Jun 30, 2025 | Wahid Nawabi
Chief Executive Officer
|
Grant | 159 | $45.3K |
| Jun 30, 2025 | Bradley Dean Truesdell
Chief Operating Officer
|
Grant | 70 | $19.9K |
| Jun 27, 2025 | Melissa Ann Brown
Officer
|
Grant | 1.1K | $314.5K |
| Jun 27, 2025 | Charles Thomas Burbage
Director
|
Grant | 609 | $169.3K |
| Jun 27, 2025 | Phillip S Davidson
Director
|
Grant | 609 | $169.3K |
| Jun 27, 2025 | James William Ferguson III
Officer
|
Grant | 872 | $242.5K |
| Jun 27, 2025 | Cindy Kay Lewis
Director
|
Grant | 609 | $169.3K |
| Jun 27, 2025 | Mary Beth Long
Director
|
Grant | 609 | $169.3K |
| Jun 27, 2025 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Grant | 1.8K | $498.0K |
| Jun 27, 2025 | Edward R Muller
Director
|
Grant | 609 | $169.3K |
| Jun 27, 2025 | Wahid Nawabi
Chief Executive Officer
|
Grant | 9.9K | $2.8M |
| Jun 27, 2025 | Stephen F Page
Director
|
Grant | 609 | $169.3K |
| Jun 27, 2025 | Brian Charles Shackley
Officer
|
Grant | 387 | $107.6K |
| Jun 27, 2025 | Trace E Stevenson
Officer
|
Grant | 2.2K | $606.5K |
| Jun 27, 2025 | Trace E Stevenson
Officer
|
Grant | 1.2K | - |
| Jun 27, 2025 | Bradley Dean Truesdell
Chief Operating Officer
|
Grant | 688 | $191.3K |
| Jun 27, 2025 | Joseph L. Votel
Director
|
Grant | 609 | $169.3K |
| Jun 24, 2025 | Melissa Ann Brown
Officer
|
Grant | 7.9K | - |
| Jun 24, 2025 | Kevin Patrick Mcdonnell
Chief Financial Officer
|
Grant | 17.1K | - |
| Jun 24, 2025 | Wahid Nawabi
Chief Executive Officer
|
Grant | 39.9K | - |
| Jun 24, 2025 | Brian Charles Shackley
Officer
|
Grant | 2.3K | - |
| Jun 24, 2025 | Trace E Stevenson
Officer
|
Grant | 3.4K | - |
| Jun 6, 2025 | Melissa Ann Brown
Officer
|
Grant | 523 | $99.8K |
| Jun 6, 2025 | Brian Charles Shackley
Officer
|
Grant | 785 | $149.8K |
| Jun 6, 2025 | Bradley Dean Truesdell
Chief Operating Officer
|
Grant | 130 | $24.8K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.